skip to main content

Main Site Navigation

Top of main content

Clinical Trials Details

Study of Perampanel as Adjunctive Treatment for Inadequately Controlled Seizures Associated With Lennox-Gastaut Syndrome

Location: Carle - Neuroscience Institute
Body site or condition: Neuroscience
Department: Neuroscience

16CNI1251 E2007-G00-338

This study is being conducted to demonstrate that perampanel given as adjunctive anti-epileptic treatment is superior to placebo in reducing the number of drop seizures in participants with inadequately controlled seizures associated with Lennox-Gastaut Syndrome (LGS)

Apply Now